DE69811404T2 - N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-flurophenyl)1,6-dihydro-1-pyrimidinyl)acetoxyl)-l-asparaginsäure aldehyde als in vivo inhibitor des interleukin-1beta konvertierenden enzyms - Google Patents

N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-flurophenyl)1,6-dihydro-1-pyrimidinyl)acetoxyl)-l-asparaginsäure aldehyde als in vivo inhibitor des interleukin-1beta konvertierenden enzyms

Info

Publication number
DE69811404T2
DE69811404T2 DE69811404T DE69811404T DE69811404T2 DE 69811404 T2 DE69811404 T2 DE 69811404T2 DE 69811404 T DE69811404 T DE 69811404T DE 69811404 T DE69811404 T DE 69811404T DE 69811404 T2 DE69811404 T2 DE 69811404T2
Authority
DE
Germany
Prior art keywords
compound
ice
interleukin
amino
acetoxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69811404T
Other languages
German (de)
English (en)
Other versions
DE69811404D1 (de
Inventor
Paul Schielke
Aurash Shahripour
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Abbott GmbH and Co KG
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott GmbH and Co KG, Warner Lambert Co LLC filed Critical Abbott GmbH and Co KG
Application granted granted Critical
Publication of DE69811404D1 publication Critical patent/DE69811404D1/de
Publication of DE69811404T2 publication Critical patent/DE69811404T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69811404T 1998-01-20 1998-11-20 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-flurophenyl)1,6-dihydro-1-pyrimidinyl)acetoxyl)-l-asparaginsäure aldehyde als in vivo inhibitor des interleukin-1beta konvertierenden enzyms Expired - Fee Related DE69811404T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7191898P 1998-01-20 1998-01-20
PCT/US1998/024848 WO1999036426A1 (en) 1998-01-20 1998-11-20 N-[2-(5-BENZYLOXYCARBONYL-AMINO-6-OXO-2-(4-FLUOROPHENYL)-1,6-DIHYDRO-1-PYRIMIDINYL)ACETO- XYL]-L-ASPARTIC ACID ALDEHYDE AS AN IN VIVO INHIBITOR OF INTERLEUKIN-1β CONVERTING ENZYME (ICE)

Publications (2)

Publication Number Publication Date
DE69811404D1 DE69811404D1 (de) 2003-03-20
DE69811404T2 true DE69811404T2 (de) 2003-12-04

Family

ID=22104428

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69811404T Expired - Fee Related DE69811404T2 (de) 1998-01-20 1998-11-20 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-flurophenyl)1,6-dihydro-1-pyrimidinyl)acetoxyl)-l-asparaginsäure aldehyde als in vivo inhibitor des interleukin-1beta konvertierenden enzyms

Country Status (11)

Country Link
EP (1) EP1049703B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002509153A (cg-RX-API-DMAC7.html)
AT (1) ATE232536T1 (cg-RX-API-DMAC7.html)
AU (1) AU1466399A (cg-RX-API-DMAC7.html)
CA (1) CA2309546A1 (cg-RX-API-DMAC7.html)
DE (1) DE69811404T2 (cg-RX-API-DMAC7.html)
DK (1) DK1049703T3 (cg-RX-API-DMAC7.html)
ES (1) ES2193589T3 (cg-RX-API-DMAC7.html)
PT (1) PT1049703E (cg-RX-API-DMAC7.html)
WO (1) WO1999036426A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA99369B (cg-RX-API-DMAC7.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653316B1 (en) 1999-05-19 2003-11-25 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6458952B1 (en) 1999-05-19 2002-10-01 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6750342B1 (en) 1999-05-19 2004-06-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
US6867217B1 (en) 1999-05-19 2005-03-15 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
US6716838B1 (en) 1999-05-19 2004-04-06 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
US6664255B1 (en) 1999-05-19 2003-12-16 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
US7015230B1 (en) 1999-05-19 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
WO2001068605A1 (en) 2000-03-13 2001-09-20 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
ATE289299T1 (de) 2000-04-05 2005-03-15 Pharmacia Corp Polyzyclisch aryl und heteroaryl substituierte 4- pyronen verwendbar als selektive hemmung von dem koagulationsprozess
AU2001251315A1 (en) 2000-04-05 2001-10-23 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
EP1274676A2 (en) 2000-04-17 2003-01-15 Pharmacia Corporation Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
WO2001087851A1 (en) * 2000-05-18 2001-11-22 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
PE20011350A1 (es) 2000-05-19 2002-01-15 Vertex Pharma PROFARMACO DE UN INHIBIDOR DE ENZIMA CONVERTIDORA DE INTERLEUCINA-1ß (ICE)
CA2416248A1 (en) 2000-07-18 2002-01-24 Neurogen Corporation 5-substituted 2-aryl-4-pyrimidinones
CA2430037A1 (en) 2000-11-20 2002-05-30 Michael S. South Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
US7119094B1 (en) 2000-11-20 2006-10-10 Warner-Lambert Company Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
US7015223B1 (en) 2000-11-20 2006-03-21 Pharmacia Corporation Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
TR201809678T4 (tr) 2001-06-26 2018-07-23 Amgen Fremont Inc Opgl ye karşi antikorlar.
MXPA04003170A (es) 2001-10-03 2004-07-08 Pharmacia Corp Compuestos policiclicos, sustituidos, provisto de 5 miembros, utiles para la inhibicion selectiva de la cascada de coagulacion.
BR0213092A (pt) 2001-10-03 2004-10-19 Pharmacia Corp Compostos heterocìclicos de 6 elementos úteis para a inibição seletiva da cascata de coagulação
MXPA05002514A (es) 2002-09-06 2005-05-27 Amgen Inc Anticuerpo monoclonal anti-il-1r1 humano terapeutico.
AU2005223767B2 (en) 2004-03-12 2011-12-01 Vertex Pharmaceuticals Incorporated Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
PL217743B1 (pl) 2004-05-15 2014-08-29 Vertex Pharma Zastosowanie inhibitorów ICE/kaspazy-1 do leczenia napadów i konwulsji w epilepsji oraz zawierające je kompozycja farmaceutyczna i zestaw
CN1980658A (zh) 2004-05-27 2007-06-13 沃泰克斯药物股份有限公司 治疗自身炎性疾病的ice抑制剂
KR20080038369A (ko) 2005-07-28 2008-05-06 버텍스 파마슈티칼스 인코포레이티드 카스파제 억제제 프로드럭
JP6006908B2 (ja) 2010-11-05 2016-10-12 ブランダイス ユニバーシティBrandeis University Ice阻害化合物およびその使用
EP3836954B1 (en) 2018-08-13 2025-05-07 Iltoo Pharma Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof
US20250283174A1 (en) 2022-05-16 2025-09-11 Institut National de la Santé et de la Recherche Médicale Methods for assessing the exhaustion of hematopoietic stem cells induced by chronic inflammation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441960A (en) * 1992-04-16 1995-08-15 Zeneca Limited 1-pyrimidinylacetamide human leukocyte elastate inhibitors
CN1118458C (zh) * 1994-03-31 2003-08-20 弗特克斯药品有限公司 作为白细胞介素抑制剂的嘧啶基衍生物

Also Published As

Publication number Publication date
EP1049703B1 (en) 2003-02-12
PT1049703E (pt) 2003-06-30
CA2309546A1 (en) 1999-07-22
JP2002509153A (ja) 2002-03-26
DK1049703T3 (da) 2003-06-02
EP1049703A1 (en) 2000-11-08
WO1999036426A1 (en) 1999-07-22
ES2193589T3 (es) 2003-11-01
ATE232536T1 (de) 2003-02-15
AU1466399A (en) 1999-08-02
ZA99369B (en) 1999-07-20
DE69811404D1 (de) 2003-03-20

Similar Documents

Publication Publication Date Title
EP1049703B1 (en) N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
DE69718050T2 (de) Sulfonamid-inhibitoren des interleukin-1-beta konvertierenden enzyms
DE60030097T2 (de) Substituierte 2-aminobenzamin caspase inhibitoren und ihre verwendung
DE69925268T2 (de) Dipeptid-Caspase-Inhibitoren und deren Verwendung
DE60112079T2 (de) Vebindungen zur modulation des rage-rezeptors
DE69631141T2 (de) Biologisch aktive peptide und ihre zubereitungen und verwendungen
DE60031577T2 (de) Hemmer der zelladhäsion
DE69908648T2 (de) Kondensierte 1,2,4-thiadiazinderivate, ihre herstellung und verwendung
DE69734215T2 (de) Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
CA2306692C (en) Dipeptide apoptosis inhibitors and the use thereof
DE69532113T2 (de) Pyrimidin-derivate als interleukin inhibitoren
DE68913762T2 (de) Diarylverbindungen als antiatherosklerotische Mittel.
DE69925914T2 (de) Succinamid hemmstoffe des interleukin-1 beta konvertierenden enzyms
DE10034623A1 (de) Heterocyclisch substituierte Pyridine als Cytokin-Inhibitoren
DE60015173T2 (de) Verbindung mit wachstumshormon-freisetzenden eigenschaften
EP0920426B9 (de) Neue thiazol-derivate mit phosphodiesterase inhibierender wirkung
DE69925581T2 (de) 1,2-diazepanderivate als inhibitoren des interleukin-1beta umwandelnden enzyms
DE69414279T2 (de) Sulfonamidaminomethylenderivate als Immunsuppressiva
DD209624A5 (de) Verfahren zur herstellung von benzimidazolverbindungen
DE3623880A1 (de) Poly-4-aminopyrrol-2-carboxamidoderivate und verfahren zu deren herstellung
EP0611776A2 (de) Neue antiviral wirksame Pseudopeptide
EP1054017B1 (de) Salze von Thrombininhibitoren
DE2535599C2 (de) Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE69812599T2 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE10034627A1 (de) Aryl-substituierte Oxazolidinone mit Cytokin inhibitorischer Wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WARNER-LAMBERT CO., MORRIS PLAINS, N.J., US

8339 Ceased/non-payment of the annual fee